AzTrials
AzTrials

Alcohol MisusePhase 2/3SmartT_ANCT06821295

Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing Homelessness

A Phase 2/3 study testing Smart-T Alcohol in people with Alcohol Misuse and Homeless, run by University of Oklahoma at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Approximately 1 out of every 3 adults experiencing homelessness has a current alcohol use disorder (AUD). Alcohol use plays a central role in increased morbidity and mortality in this population, with some studies suggesting it plays a direct role in as many as 17% of deaths. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Alcohol Misuse, Homeless
What is being tested?
Smart-T Alcohol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
600 participants
Where
1 siteUnited States
Study dates
5 Mar 2025to 30 Apr 2029
Phase
Phase 2/3
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • At least 18 years old
  • 8 or above on the AUDIT
  • Receiving shelter-based services
  • Consuming 1 or more standard drink of alcohol in the past week
  • Score of 4 or higher on the REALM-SF
  • Score under 8 on the 6CIT

Who cannot join

  • Under 18 years old
  • Not meeting other inclusion criteria

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, 73104

    Michael S Businelle, PhD, 405-271-8001 ext. 50460, michael-businelle@ouhsc.edu

    Krista Kezbers, PhD, 405-271-8001 ext. 45042, krista-kezbers@ouhsc.edu

    Recruiting

Other trials in United States

About this study

Official title: Efficacy of a Smartphone-Based Just-In-Time Adaptive Intervention to Reduce Drinking Among Adults Experiencing Homelessness

Approximately 1 out of every 3 adults experiencing homelessness has a current alcohol use disorder (AUD). Alcohol use plays a central role in increased morbidity and mortality in this population, with some studies suggesting it plays a direct role in as many as 17% of deaths. Alcohol is also a leading cause of homelessness and contributes to its chronicity by inhibiting progress toward obtaining employment and a stable living environment. Shelter-based treatments are common, but compliance is often poor. There are many documented challenges to effectively implementing traditional evidence-based interventions in shelter settings. In the current project, we will conduct a randomized controlled trial. Adults currently experiencing homelessness who report hazardous alcohol use (N = 600) will be recruited from five shelters across the Dallas, TX and Oklahoma City, OK metropolitan areas. Individuals will attend screening and training visits, then complete one week of self-monitoring (via smartphone app) before being randomized to receive either standard shelter-based treatment (Usual Care; UC), or the Smart-T Alcohol intervention + UC. The Smart-T Alcohol intervention offers on-demand content and automated contextually tailored messages to reduce alcohol consumption. The intervention period will span eight-weeks (i.e., weeks 2-9), with follow-up assessments occurring at weeks 9, 13, and 26. All participants will complete brief daily smartphone-based surveys for 13 weeks. Aims of the project will be to assess the effects of the Smart-T Alcohol intervention on alcohol use and alcohol-related problems (Aim 1), intervention effects on key drinking risk indicators and their mediation of use outcomes (Aim 2), and identify specific subpopulations (e.g., women, racial/ethnic minorities, younger adults; Exploratory Aim 3) for which the intervention is most effective. Findings will provide a rigorous evaluation of the efficacy of the Smart-T Alcohol intervention and guide future smartphone-based interventions for this population.

Read the detailed description

The study will test the efficacy of a novel smartphone-based alcohol use reduction intervention (i.e., Smart-T Alcohol) relative to Usual Care in an RCT of heavy-drinking adults experiencing homelessness (N = 600). Participants will complete a screening visit on-site at one of our partnering shelters. Eligible participants will receive training in our smartphone-based assessment platform and may be provided with a compatible device if they do not own one. All participants will use the app to complete four brief (1-2 minute) daily EMAs for 1 week to obtain baseline drinking levels and psychosocial drinking risk factors (e.g., drinking urge, mood, alcohol availability, abstinence motivation). Individuals that complete at least 50% of the daily surveys will then be told if they were randomized to either standard shelter-based treatment (Usual Care; UC) or UC + Smart-T Alcohol intervention (1:1 allocation). The Smart-T Alcohol Intervention will last for eight weeks. An additional 4 weeks of EMA following treatment completion will be used to determine if intervention effects are maintained in the 4-weeks following the end of treatment. Follow-up assessments will occur via Insight(TM) app, at shelters, or via phone at end-of-treatment (i.e., 9 weeks post-enrollment), as well as 13- and 26-weeks post-enrollment. Participants in both groups will complete daily EMAs for a total of 13 weeks (see participant flow in Figure 2). Considering both established recommendations for treatment trials of AUDs and our emphasis on a harm reduction approach for this population, our primary efficacy outcome (Aim 1) will be total alcohol consumption, with # of drinking days and # of heavy drinking days serving as secondary outcomes. Given our preliminary study revealed EMA reports had substantially better agreement with objective markers of alcohol use compared to TLFB, EMA will be used to calculate primary and secondary outcomes. However, analyses will be repeated using TLFB-based outcomes (i.e., 9, 13, and 26-weeks) to facilitate direct comparisons to prior research and examine intervention effects. Additional analyses will examine intervention effects on key drinking risk factors per our conceptual framework (i.e., drinking urge, mood, alcohol availability, abstinence motivation) and whether these effects mediate treatment outcome (Aim 2), as well as subpopulations for whom the intervention may be more or less effective (e.g., women, younger adults, those with comorbid mental health or substance use problems, individuals engaging more heavily with shelter services; Exploratory Aim 3).

Interventions. Over the past 9 years, Dr. Businelle (MPI) has led the development of the InsightTM mHealth Platform. This platform enables researchers to rapidly create innovative smartphone-based studies that include EMA and just-in-time adaptive interventions (JITAI) in a matter of weeks. The platform has supported 113 research studies to date (60 of these studies received funding from the NIH). The InsightTM platform was used to create the Smart Treatment (Smart-T) suite of apps, including the Smart-T Alcohol app that we tested in our recently completed NIAAA-funded R34 study. All participants will receive a version of the InsightTM app (UC or Smart-T Alcohol) on their personal phone or a study phone that is loaned to them.

Usual Care (UC). We will carefully document engagement with AUD treatments (shelter and non-shelter based) via EMA each day for examination in exploratory moderator analyses (Aim 3). All participants at the recruitment sites have access to 12-step support groups (e.g., Alcoholics Anonymous), intensive or supportive outpatient services, and medical and/or psychiatric care. Though initially conceived as part of the Smart-T Alcohol intervention, for ethical reasons individuals in either group who report heavy drinking episode(s) will receive feedback about the negative health effects of heavy drinking and those who report high-intensity drinking (i.e., Women: 8 drinks/day; Men: 10 drinks/day) will be immediately referred for additional treatment services via a designated shelter referral/contact (i.e., shelter contacts will receive encrypted emails that state when study participants report high-intensity drinking). All five shelters conduct a needs assessment as part of their intake process. Access to supportive services (e.g., computer access, laundry facilities, physical and mental healthcare) are also provided as part of standard shelter services either in-house or through partnerships with local organizations.

Usual Care + Smart-T Alcohol. Participants in this condition will receive UC and gain access to the Smart-T Alcohol intervention, which includes two core components: 1) an on-demand "Tips" function/button; and 2) an algorithm that uses EMA responses to assess current risk for alcohol use and automatically delivers tailored messages to help participants achieve their daily drinking goal (i.e., stay sober, cut down on drinking, no drinking goal). On days when there is an abstinence or reduction goal, the app will provide tailored treatment messages that aim to help participants achieve their chosen goal. On days when there is no drinking goal, the app's gain-framed messages will focus on increasing motivation to set a reduction or abstinence goal. The app has been customized using iterative, user-centered design procedures to increase clarity and helpfulness of messages and ensure app usability in this population.

Being tested
Smart-T Alcohol, Usual Care
Keywords
Just In Time Adaptive Intervention, Mobile Health, homeless, ecological momentary assessment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Smart-T AlcoholOther

    The Smart-T Alcohol intervention offers on-demand content and automated contextually tailored messages to reduce alcohol consumption. The intervention period will span eight-weeks (i.e., weeks 2-9), with follow-up assessments occurring at weeks 9, 13, and 26. All participants will complete brief daily smartphone-based surveys for 13 weeks.

  • Usual CareOther

    Participants will receive standard shelter-based treatment (Usual Care) along with completing surveys and assessments.

Study groups in NCT06821295
Study groupRoleWhat they receive
Usual Care (UC)Active comparatorAll participants at the recruitment sites have access to 12-step support groups, intensive or supportive outpatient services, and/or medical and/or psychiatric care. All participants that report heavy drinking episode(s) during daily smartphone-based surveys will be referred for additional treatment services via a designated shelter referral/contact.
Receives: Other: Usual Care
Usual Care + Smart-T AlcoholExperimentalThe Smart-T Alcohol arm will receive Usual Care plus the Smart-T Alcohol smartphone-based intervention which includes two core components: 1) an on-demand "Tips" function/button; and 2) an algorithm that uses daily survey responses to assess current risk for alcohol use and automatically delivers tailored messages to help participants achieve their daily drinking goal.
Receives: Other: Smart-T Alcohol; Other: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of drinks per week

    The number of drinks per week reported during daily EMAs.

    Measured: 13 weeks

  2. Number of heavy drinking days

    Number of heavy drinking days reported in daily EMAs (defined in alignment with NIAAA guidelines as ≥ 5 drinks/day for men and ≥ 4 drinks/day for women).

    Measured: 13 weeks

  3. Total number of drinking days

    The total number of drinking days will be calculated using EMA data.

    Measured: 13 weeks

  4. Slopes of key drinking factors over time(e.g., urge, mood, alcohol availability, motivation)

    Analyses will determine the effects of tailored intervention messages (Smart-T app group) versus no intervention messages (Usual Care) on key drinking risk factors over time.

    Measured: 13 weeks

Secondary outcomes (4)
  1. Number of drinks per week

    The number of drinks per week will be calculated using timeline follow-back data.

    Measured: 13 weeks

  2. Number of heavy drinking days

    The number of heavy drinking days will be calculated using timeline follow-back data.

    Measured: 13 weeks

  3. Total number of drinking days

    The total number of drinking days will be calculated using timeline follow-back data.

    Measured: 13 weeks

  4. Alcohol-related problems

    Total scores on the end of treatment Short Inventory of Problems (SIP) measure controlling for baseline SIP scores.

    Measured: End of treatment and each follow-up assessment (i.e., 9, 13, and 26 weeks).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2025
  2. Study start5 Mar 2025
  3. Primary completion30 Apr 2029 (estimated)
  4. Study completion30 Apr 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06821295
Sponsor's protocol ID
17400
Other IDs
R01AA031280
Acronym
SmartT_A
Status last verified
Apr 2026
First submitted
6 Feb 2025
Last updated
1 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data will be shared via the NIMH Data Archive (NDA) and/or other repositories.

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Smart-T Alcohol in people with Alcohol Misuse and Homeless, run by University of Oklahoma at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Michael Businelle, PhD (405-271-8001 ext. 50460, michael-businelle@ouhsc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of drinks per week (time frame: 13 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in